Suppr超能文献

相似文献

5
Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).
Int J Gynecol Pathol. 2019 Nov;38(6):543-551. doi: 10.1097/PGP.0000000000000545.
6
c-KIT Analysis and Targeted Molecular Sequencing of Mesonephric Carcinomas of the Female Genital Tract.
Am J Surg Pathol. 2020 Apr;44(4):495-502. doi: 10.1097/PAS.0000000000001403.
7
Mesonephric Adenocarcinoma and Mesonephric-like Adenocarcinoma of the Urinary Tract.
Mod Pathol. 2023 Jan;36(1):100031. doi: 10.1016/j.modpat.2022.100031.

引用本文的文献

3
Malignant Wolffian adnexal tumor in the ovary: a case report and literature review.
Front Oncol. 2025 Mar 18;15:1526030. doi: 10.3389/fonc.2025.1526030. eCollection 2025.
5
Cellular origins of mucinous ovarian carcinoma.
J Pathol. 2025 May;266(1):9-25. doi: 10.1002/path.6407. Epub 2025 Mar 3.
10
Mesonephric adenocarcinoma of the uterine cervix with a prominent spindle cell component.
Oncol Lett. 2024 Aug 22;28(5):508. doi: 10.3892/ol.2024.14641. eCollection 2024 Nov.

本文引用的文献

1
KRAS Inhibition with Sotorasib in Advanced Solid Tumors.
N Engl J Med. 2020 Sep 24;383(13):1207-1217. doi: 10.1056/NEJMoa1917239. Epub 2020 Sep 20.
2
Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer.
JCO Precis Oncol. 2019 Jun 6;3. doi: 10.1200/PO.18.00410. eCollection 2019.
4
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Mod Pathol. 2020 Aug;33(8):1606-1617. doi: 10.1038/s41379-020-0514-3. Epub 2020 Mar 12.
5
Lineage plasticity in cancer: a shared pathway of therapeutic resistance.
Nat Rev Clin Oncol. 2020 Jun;17(6):360-371. doi: 10.1038/s41571-020-0340-z. Epub 2020 Mar 9.
7
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary.
Nat Commun. 2020 Jan 2;11(1):44. doi: 10.1038/s41467-019-13806-x.
8
Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior.
Am J Surg Pathol. 2020 Apr;44(4):429-443. doi: 10.1097/PAS.0000000000001401.
9
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.
Nature. 2019 Nov;575(7781):217-223. doi: 10.1038/s41586-019-1694-1. Epub 2019 Oct 30.
10
The KRAS Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.
Cancer Discov. 2020 Jan;10(1):54-71. doi: 10.1158/2159-8290.CD-19-1167. Epub 2019 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验